Guamán-Ortiz Luis Miguel, Orellana Maria Isabel Ramirez, Ratovitski Edward A
1 Departamento de Ciencias de la Salud, Universidad Técnica Particular de Loja, Loja, Ecuador ; 2 Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Curr Genomics. 2017 Apr;18(2):132-155. doi: 10.2174/1389202917666160803150639.
Cell death is an innate capability of cells to be removed from microenvironment, if and when they are damaged by multiple stresses. Cell death is often regulated by multiple molecular pathways and mechanism, including apoptosis, autophagy, and necroptosis. The molecular network underlying these processes is often intertwined and one pathway can dynamically shift to another one acquiring certain protein components, in particular upon treatment with various drugs. The strategy to treat human cancer ultimately relies on the ability of anticancer therapeutics to induce tumor-specific cell death, while leaving normal adjacent cells undamaged. However, tumor cells often develop the resistance to the drug-induced cell death, thus representing a great challenge for the anticancer approaches. Numerous compounds originated from the natural sources and biopharmaceutical industries are applied today in clinics showing advantageous results. However, some exhibit serious toxic side effects. Thus, novel effective therapeutic approaches in treating cancers are continued to be developed. Natural compounds with anticancer activity have gained a great interest among researchers and clinicians alike since they have shown more favorable safety and efficacy then the synthetic marketed drugs. Numerous studies in vitro and in vivo have found that several natural compounds display promising anticancer potentials. This review underlines certain information regarding the role of natural compounds from plants, microorganisms and sea life forms, which are able to induce non-apoptotic cell death in tumor cells, namely autophagy and necroptosis.
细胞死亡是细胞在受到多种应激损伤时从微环境中被清除的一种固有能力。细胞死亡通常受多种分子途径和机制调控,包括凋亡、自噬和坏死性凋亡。这些过程背后的分子网络往往相互交织,一条途径可以动态转变为另一条途径,特别是在使用各种药物治疗时会获得某些蛋白质成分。治疗人类癌症的策略最终依赖于抗癌疗法诱导肿瘤特异性细胞死亡的能力,同时使相邻的正常细胞不受损伤。然而,肿瘤细胞常常对药物诱导的细胞死亡产生抗性,从而给抗癌方法带来巨大挑战。如今,许多源自天然来源和生物制药行业的化合物应用于临床并显示出有利的结果。然而,一些化合物表现出严重的毒副作用。因此,仍在继续开发治疗癌症的新型有效治疗方法。具有抗癌活性的天然化合物因其显示出比合成上市药物更有利的安全性和有效性,而在研究人员和临床医生中都引起了极大的兴趣。许多体外和体内研究发现,几种天然化合物具有有前景的抗癌潜力。本综述强调了有关来自植物、微生物和海洋生物形式的天然化合物作用的某些信息,这些化合物能够在肿瘤细胞中诱导非凋亡性细胞死亡,即自噬和坏死性凋亡。
Curr Genomics. 2017-4
Cancer Drug Resist. 2023-10-19
Cancer Lett. 2018-2-1
Biochem Pharmacol. 2015-3-1
Semin Cancer Biol. 2016-6-2
Biomolecules. 2024-12-30
Anticancer Agents Med Chem. 2025
Int J Mol Sci. 2023-10-1
Biomedicines. 2021-9-29
Cancers (Basel). 2021-1-15
Cancers (Basel). 2020-9-4
PLoS One. 2015-10-16
Curr Cancer Drug Targets. 2015
Cell Mol Life Sci. 2015-12
Acta Biochim Biophys Sin (Shanghai). 2015-10